Biotechnology Sanofi’s Multiple Sclerosis Antibody Shows Reduction Of Disease Activity – Sanofi (NASDAQ:SNY) Read more
Biotechnology Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years – Novartis (NYSE:NVS) Read more
Biotechnology Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) – Athira Pharma (NASDAQ:ATHA) Read more